Intra-Cellular Therapies Expands Portfolio with Strategic Acquisition, Reports Promising CAPLYTA Study Results at ACNP Annual Meeting

Breaking News: Intra-Cellular Therapies Announces Acquisition of CAPLYTA; Shares Surge Following Positive Phase 3 Findings

Date: December 11, 2024

Intra-Cellular Therapies Inc.
(NASDAQ: ITCI), a leading biopharmaceutical company specializing in innovative treatments for neuropsychiatric and neurodegenerative diseases, has made

More Intra cellular Therapies Inc 's News

Intra cellular Therapies Inc Intra-Cellular Therapies Reports Key Findings from CAPLYTA MDD Phase 3 Studies at ACNP Annual Meeting, December 11, 2024

Intra cellular Therapies Inc Augmenting Psychiatric Care Lumateperone Demonstrates Promising Results in Schizophrenia and Major Depress... November 5, 2024

Intra cellular Therapies Inc Intra-Cellular Therapies Strengthens Leadership Team with New CFO Appointment August 7, 2024

Intra cellular Therapies Inc Lumateperone Shows Promise as Adjunctive Therapy for Major Depressive Disorder A Positive Phase 3 Trial Evaluation June 18, 2024

Intra cellular Therapies Inc Intra-Cellular Therapies Presents Revolutionary Data at ASCP Annual Meeting, Demonstrates Strong Revenue Growth May 23, 2024

Intra cellular Therapies Inc Intra-Cellular Therapies: Balancing Success and Struggles in the Biopharmaceutical Landscape April 24, 2024

Intra cellular Therapies Inc Intra-Cellular Therapies Raises $500 Million in Public Stock Offering for CNS Therapeutic Development and Commercialization April 18, 2024

Intra cellular Therapies Inc Game-Changing Antidepressant Drug Lumateperone Sets New Standards: Intra-Cellular Therapies Posts Staggering 75.56% YoY Revenue Growth April 16, 2024

More Merger and Acquisition News

Merger and Acquisition Tampa, FL March 21, 2025: Better Choice Company, Inc (NYSE American: BTTR) Enhances Growth Potential with Shareholder Approval and Innovative Royalty Distribution Plan March 21, 2025

Merger and Acquisition NV5 Strengthens North Carolina Operations with CRS Survey Acquisition: A Strategic Move for Growth March 21, 2025

Merger and Acquisition Palomar Holdings Expands Horizons: Strategic Acquisition of Advanced AgProtection Signals Growth in Ag Insurance, March 20, 2025

Submit

Previous News

uniQures Ambitious Public Offering: A Strategic Play in the Gene Therapy Arena

Lithium Argentina Eyes Global Markets with Strategic Domicile Shift and Strong Production Outlook

Microbot Medical Secures $8.6 Million: A Strategic Step Towards Growth in the Medical Tech Landscape,

Navigating the Crypto Storm: Bit Origin Ltds Struggle for Survival and Market Viability

Lifeward Raises $5 Million in Direct Offering to Propel Innovation in Rehabilitation Solutions,

Amesite Inc. Raises $3.6 Million in Robust Public Offering: Paving the Way for Innovative AI Solutions,

Senseonics Holdings, Inc. Moves Forward Amid Market Challenges: A Glimpse into the Future of Diabetes Management

New York Mortgage Trust, Inc. Announces $75 Million Senior Notes Offering Amidst Strategic Growth Initiatives,

Alterity Therapeutics: Charting a Course for Breakthroughs in Neurodegenerative Disease Treatments with Strategic Leadership Enhancements,

Uniti Group Inc. Sets New Financial Milestone with $589 Million Fiber Securitization Notes Offering, Enhancing Growth Strategy and Debt Management,